The relationship between self-efficacy and treatment satisfaction among patients with anticoagulant therapy: a cross-sectional study from a developing country

被引:0
作者
Samah W. Al-Jabi
Amal Abu Dalu
Amer A. Koni
Maher R. Khdour
Adham Abu Taha
Riad Amer
Sa’ed H. Zyoud
机构
[1] An-Najah National University,Department of Clinical and Community Pharmacy, College of Medicine and Health Sciences
[2] An-Najah National University Hospital,Division of Clinical Pharmacy, Department of Hematology and Oncology
[3] Al-Quds University,Faculty of Pharmacy
[4] An-Najah National University,Department of Biomedical Sciences, Faculty of Medicine and Health Sciences
[5] An-Najah National University Hospital,Department of Pathology
[6] An-Najah National University,Department of Medicine, College of Medicine and Health Sciences
[7] An-Najah National University Hospital,Department of Hematology and Oncology
[8] An-Najah National University,Poison Control and Drug Information Center (PCDIC), College of Medicine and Health Sciences
[9] An-Najah National University Hospital,Clinical Research Center
来源
Thrombosis Journal | / 20卷
关键词
Self-efficacy; SES6C; Treatment satisfaction; Burden; Benefit; ACTS; Anti-coagulant; NOAC;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 317 条
[1]  
Samsa G(2004)A new instrument for measuring anticoagulation-related quality of life: development and preliminary validation Health Qual Life Outcomes 2 22-1394
[2]  
Matchar DB(2018)Survey of antithrombotic treatment in rural patients (>60 years) with atrial fibrillation in East China Sci Rep 8 6830-561
[3]  
Dolor RJ(2009)Multinational development of a questionnaire assessing patient satisfaction with anticoagulant treatment: the 'Perception of anticoagulant treatment Questionnaire' (PACT-Q) Health Qual Life Outcomes 7 9-87
[4]  
Wiklund I(2018)COSIMO - patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study Thromb J 16 21-48
[5]  
Hedner E(2015)Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score J Am Coll Cardiol 65 1385-1996
[6]  
Wygant G(2020)The anti-clot treatment scale (ACTS): validation of the translated Arabic version among patients undergoing warfarin therapy in Saudi Arabia Health Qual Life Outcomes 18 215-1126
[7]  
Hauch O(2018)Anticoagulant preferences and concerns among venous thromboembolism patients Thromb Haemost 118 553-43
[8]  
Marple CB(2018)Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillation Patient Prefer Adherence 12 79-389
[9]  
Edwards R(2012)A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence Patient Prefer Adherence 6 39-741
[10]  
Wei Y(2017)Patient satisfaction after switching from warfarin to apixaban in patients with nonvalvular atrial fibrillation: AGAIN study Patient Prefer Adherence 11 1987-569